Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
More protection from early breast cancer recurring with letrozole, study shows
June 23rd, 2005
Initial treatment with letrozole offers significantly greater post-surgery protection against breast cancer recurrence than does tamoxifen in postmenopausal women with early breast cancer (19% less risk of recurrence, p=0.003), according to newly updated results of the Breast International Group 1-98 trial. In addition, the data showed letrozole reduced the risk of cancer spreading to other parts of the body (distant metastases) by 27% (p=0.0012). "In our study, letrozole out-performed tamoxifen in a number of critical endpoints, among them reducing both the risk of recurrence and the risk of distant metastases in postmenopausal women with hormone...
Source: Women's Health Weekly (2005-06-23)
|
